专利号:US-2024167006-A1 优先权日:2022-06-09 标题 :High production of recombinant protein by making cell hybrids and enriching for a preferred mitochondrial phenotype 发明人:FORM LAWRENCE; NGO KATHY 权利人:CHO PLUS INC 摘要:This disclosure provides a technology for producing cells and cell lines that are capable of manufacturing a recombinant protein more efficiently and in a more cost effective manner. Cells are engineered or fused together to make a population of cell hybrids. The hybrids are then enriched for a mitochondria phenotype that supports and enhances protein synthesis and secretion. The phenotype may include a higher content of mitochondria per cell, a high or low cellular content of reactive oxygen species (ROS), and/or a high or low mitochondria membrane potential. The hybrids may also be enriched for a high content of endoplasmic reticulum. Producer cell lines obtained in this fashion may produce as much as 10 or 15 times the amount of protein per cell than the parental cell line. The producer cells can be used for efficient manufacture of recombinant proteins suitable for use in any industrial process, such as the making of pharmaceutical agents and food ingredients.
专利号:WO-2025128096-A1 优先权日:2023-12-13 标题:High production of recombinant protein by making cell hybrids and enriching for a preferred mitochondrial phenotype 发明人:FORMAN LAWRENCE; NGO KATHY 权利人:CHO PLUS INC 摘要:This disclosure provides a technology for producing cells and cell lines that are capable of manufacturing a recombinant protein more efficiently and in a more cost effective manner. Cells are engineered or fused together to make a population of cell hybrids. The hybrids are then enriched for a mitochondria phenotype that supports and enhances protein synthesis and secretion. The phenotype may include a higher content of mitochondria per cell, a high or low cellular content of reactive oxygen species (ROS), and/or a high or low mitochondria membrane potential. The hybrids may also be enriched for a high content of endoplasmic reticulum. Producer cell lines obtained in this fashion may produce as much as 10 or 15 times the amount of protein per cell than the parental cell line. The producer cells can be used for efficient manufacture of recombinant proteins suitable for use in any industrial process, such as the making of pharmaceutical agents and food ingredients.
参考文献:10.1016/j.rbmo.2009.10.011 摘要:Cecconi S, Rossi G, Santilli A, Stefano LD, Hoshino Y, Sato E, Palmerini MG, Macchiarelli G. Akt expression in mouse oocytes matured in vivo and in vitro. Reprod Biomed Online. 2010 Jan;20(1):35–41. doi: 10.1016/j.rbmo.2009.10.011. 参考文献:10.1016/j.rbmo.2009.10.009 摘要:Nakhuda GS, Douglas NC, Thornton MH, Guarnaccia MM, Lobo R, Sauer MV. Anti-Müllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors. Reprod Biomed Online. 2010 Jan;20(1):42–7. doi: 10.1016/j.rbmo.2009.10.009. 参考文献:10.1016/j.contraception.2009.10.004 摘要:Steiner AZ, Stanczyk FZ, Patel S, Edelman A. Antimullerian hormone and obesity: insights in oral contraceptive users. Contraception. 2010 Mar;81(3):245–8. doi: 10.1016/j.contraception.2009.10.004. 参考文献:10.1016/j.ejogrb.2011.06.006 摘要:Skałba P, Cygal A, Madej P, Dąbkowska-Huć A, Sikora J, Martirosian G, Romanik M, Olszanecka-Glinianowicz M. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome European Journal of Obstetrics & Gynecology and Reproductive Biology. 2011 Oct;158(2):254–9. doi: 10.1016/j.ejogrb.2011.06.006. 参考文献:10.1210/jc.2011-1064 摘要:Desai SS, Achrekar SK, Pathak BR, Desai SK, Mangoli VS, Mangoli RV, Mahale SD. Follicle-stimulating hormone receptor polymorphism (G-29A) is associated with altered level of receptor expression in Granulosa cells. J Clin Endocrinol Metab. 2011 Sep;96(9):2805–12. doi: 10.1210/jc.2011-1064.